| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 04/13/2005 | EP1521744A1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 04/13/2005 | EP1073640B1 Naphthalene derivatives, their production and use |
| 04/13/2005 | CN1606561A Production of ionic liquids |
| 04/13/2005 | CN1606440A Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them |
| 04/13/2005 | CN1606439A Cis-imidazolines |
| 04/13/2005 | CN1605586A Alpha-substituted 2-methyl-5-nitroimidazole-1-ethanol derivatives |
| 04/13/2005 | CN1196795C Novel method for preparing synthesis intermediates |
| 04/13/2005 | CN1196681C (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers |
| 04/12/2005 | US6878829 Reacting amino ester with cyanoacetic ester to give cyanoacetamide, catalytic hydrogenation |
| 04/12/2005 | US6878828 Coupling cysteine with benzonitrile, then esterifying, alkylating, hydrolyzing and reacting with acids to form 2-methylcysteine |
| 04/12/2005 | US6878743 Controlling apoptosis; central nervous system disorders |
| 04/12/2005 | US6878742 Alzheimer's disease; Down's syndrome |
| 04/12/2005 | US6878735 Multi-substituted imidazolines and method of use thereof |
| 04/12/2005 | US6878734 Gastrin and cholecystokinin receptor ligands(II) |
| 04/12/2005 | US6878731 Imidazole alkaloids from Lepidium meyenii and methods of usage |
| 04/12/2005 | US6878720 VEGF receptor tyrosine kinase inhibitors |
| 04/12/2005 | CA2122571C Adhesion receptor antagonists |
| 04/07/2005 | WO2005030794A2 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | WO2005030736A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/07/2005 | WO2005030731A1 Gamma-secretase inhibitors |
| 04/07/2005 | WO2005030705A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030704A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2004110364A9 Thiotungstate analogues and uses thereof |
| 04/07/2005 | WO2004101530A8 A method for producing diverse set of dithioate compounds |
| 04/07/2005 | WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 04/07/2005 | WO2004048922A3 Bead-based detection of ligand-gpcr-g protein complexes |
| 04/07/2005 | WO2004014871A8 Vanilloid receptor ligands and their use in treatments |
| 04/07/2005 | WO2003030612A3 Methods for modulating activity of the fxr nuclear receptor |
| 04/07/2005 | WO2003028728A8 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
| 04/07/2005 | US20050075390 HIV protease inhibitors |
| 04/07/2005 | US20050075378 Modulators of peroxisome proliferator activated receptors (ppar) |
| 04/07/2005 | US20050075376 for inhibiting hepatitis C NS5B RNA-dependent RNA polymerase; exemplified by ethyl 1-cyclohexyl-5-(4-benzyloxyphenyl)-1H-pyrazole-3-carboxylate |
| 04/07/2005 | US20050075372 Method for controlling particular insect pest by applying anthranilamide compounds |
| 04/07/2005 | US20050075366 dextrorotatory and levo-rotatory enantiomers; specific to alpha2B adrenergic receptors |
| 04/07/2005 | US20050075337 Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease |
| 04/07/2005 | US20050075323 Beta3 adrenergic receptor agonists and uses thereof |
| 04/07/2005 | US20050075316 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmai agents; anticancer agents; astaxanthin |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | CA2539823A1 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | CA2539744A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/07/2005 | CA2539117A1 Inhibitors of histone deacetylase |
| 04/07/2005 | CA2539042A1 Gamma-secretase inhibitors |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives |
| 04/06/2005 | CN1604778A Cis-imidazolines |
| 04/06/2005 | CN1604774A 血管生成抑制剂 An angiogenesis inhibitor |
| 04/06/2005 | CN1603312A Process for synthesis of sodium glycididazole |
| 04/06/2005 | CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/06/2005 | CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds |
| 04/06/2005 | CN1195737C HIV proteinase inhibitor |
| 04/06/2005 | CN1195735C Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/06/2005 | CN1195734C Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
| 04/05/2005 | US6875884 Urea derivatives as inhibitors for CCR-3 receptor |
| 04/05/2005 | US6875883 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists |
| 04/05/2005 | US6875882 Ferroelectric liquid crystals, antihistamines, antiinflammatory agents, viricides |
| 04/05/2005 | US6875782 Antidiabetic agents, dietetics, anticancer agents |
| 04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
| 04/05/2005 | US6875775 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/05/2005 | US6875768 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same |
| 04/05/2005 | US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
| 04/05/2005 | US6875764 Urea and thiourea compounds useful for treatment of coccidiosis |
| 04/05/2005 | US6875438 Alopecia therapy; skin disorders |
| 04/05/2005 | CA2371012C 4-(1h-pyrrol-1-yl) imidazoles |
| 03/31/2005 | WO2005028446A1 Ionic liquid and method of reaction using the same |
| 03/31/2005 | WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 03/31/2005 | WO2005028425A2 Amidines and derivatives thereof and pharmaceutical compositions containing them |
| 03/31/2005 | WO2005005394A3 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 03/31/2005 | WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| 03/31/2005 | US20050070721 PH-sensitive polymeric micelles for drug delivery |
| 03/31/2005 | US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents |
| 03/31/2005 | US20050070717 Halogen-free ionic liquids |
| 03/31/2005 | US20050070588 Imidazolyl inhibitors of 15-lipoxygenase |
| 03/31/2005 | US20050070581 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
| 03/31/2005 | US20050070555 Aroyl pyridinones |
| 03/31/2005 | US20050070539 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 03/31/2005 | US20050069912 Energy transfer dyes with enhanced fluorescence |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | US20050066451 Para-phenylenediamine derivatives comprising a cyclic diaza group substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers |
| 03/31/2005 | CA2539842A1 Amidines and derivatives thereof and pharmaceutical compositions containing them |
| 03/30/2005 | EP1517680A1 Benzoic acid derivatives as modulators of ppar alpha and gamma |
| 03/30/2005 | EP1264826B1 Novel imidazoline compounds |
| 03/30/2005 | CN1602314A Copper deposition method using copper formate complexes |
| 03/30/2005 | CN1602298A Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1601380A 干燥薄膜光阻剂 Dry film photoresist |
| 03/30/2005 | CN1194970C Preparation method of 2-nitroimidazole |
| 03/30/2005 | CN1194964C P-methylsulfonyl phenylacrylate derivative and its prepn process and anti-inflammatory effect |
| 03/29/2005 | US6872852 Polyamine analogues as cytotoxic agents |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | US6872741 Sodium channel modulators |
| 03/29/2005 | CA2244190C Method of producing press-moulding materials with polyisocyanate binders and using latent, heat-activable catalysts |
| 03/29/2005 | CA2241362C Compositions and processes for treating subterranean formations |
| 03/29/2005 | CA2097444C Angiotensin ii antagonist imidazole derivatives, their preparation and their therapeutic use |
| 03/24/2005 | WO2005026110A1 Optically active 3,3'-dithiobis(2-amino-2methylpropionic acid) derivative and process for producing optically active 2-amino-3-mercapto-2-methylpropionic acid derivative |
| 03/24/2005 | WO2004103282A3 Compounds, compositions and methods |
| 03/24/2005 | WO2004087653A3 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 |
| 03/24/2005 | WO2004087075A3 Compositions and methods for treating cancer |
| 03/24/2005 | WO2004085421A3 Bioreductively-activated prodrugs |
| 03/24/2005 | WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors |
| 03/24/2005 | US20050065350 Method for forming a carbon-carbon or carbon-heteroatom linkage |